To be exact, the average weight time for a cardiologist appointment in U.S. cities is 32.7 days. This is a 23% increase compared to 2022 and a 74% increase compared to 2004. To be exact, the average weight time for a cardiologist appointment in U.S. cities is 32.7 days. This is a 23% increase compared to 2022 and a 74% increase compared to 2004. | | |
|
The self-expanding valve, which gained CE mark approval back in 2020, is available in multiple sizes and can be fully retrieved and repositioned as it is implanted. The self-expanding valve, which gained CE mark approval back in 2020, is available in multiple sizes and can be fully retrieved and repositioned as it is implanted. | | |
|
PPMI after aortic valve surgery is known to increase certain risks for patients, but its impact after mitral valve procedures is unclear. A team of researchers aimed to learn more, tracking data from more than 4,500 patients. PPMI after aortic valve surgery is known to increase certain risks for patients, but its impact after mitral valve procedures is unclear. A team of researchers aimed to learn more, tracking data from more than 4,500 patients. | | |
|
|
"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview. "The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview. | | |
|
The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure. The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure. | | |
|
The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA. The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA. | | |
|
Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial. Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial. | | |
|
|
Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997. Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997. | | |
|
Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic. Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic. | | |
|
The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States. The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States. | | |
|
|
A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions. A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions. | | |
|
Once the model is further validated, it could help guide providers in determining how to manage thyroid nodules. Once the model is further validated, it could help guide providers in determining how to manage thyroid nodules. | | |
|